pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,422 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1024Endpoints778BioPharma Dive297BioSpace215Fierce Biotech203onclive165raps74globenewswire health
therapy area
allOncology6029Rare Disease1434Cardiology1089Hematology1025Immunology1000Vaccines902Pulmonology
  • Federal grant delays could jeopardize essential disability services, research
    Disability researchers across the country worry about their jobs, and the future of their institutions, as a delay in issuing federal grants drags on.
    STAT · 2mo ago↗ source
  • STAT+: CMS recalculates Medicare Advantage star ratings again, adding more volatility to program
    Medicare Advantage plans that receive four out of five stars or better get bonus payments, which have ballooned to $16 billion this year.
    STAT · 2mo ago↗ source
  • STAT+: FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy
    A panel of advisers to FDA gave its endorsement to a seasonal mRNA flu vaccine that was developed by Moderna and that earlier this year became the subject of controversy.
← prev
page 31 of 57
next →
73
fda recalls47
fda medwatch38
fda press28
899
Psychiatry & CNS712
Ophthalmology421
Endocrinology & Metabolism382
Pain375
Infectious Disease356
STAT · 2mo ago
↗ source
  • Moderna flu vaccine wins unanimous support from FDA panel
    The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year.
    BioPharma Dive · 2mo ago↗ source
  • STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data
    Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.
    STAT · 2mo ago↗ source
  • STAT+: Eli Lilly ends 340B drug discounts to some hospitals for failing to provide claims data
    Making good on its threat, Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program.
    STAT · 2mo ago↗ source
  • New hope in treating Huntington’s disease and a report card on RFK Jr.’s promises
    This week on "The Readout LOUD" podcast: new hope in treating Huntington's disease and a report card on RFK Jr.'s promises. Listen now.
    STAT · 2mo ago↗ source
  • Ebola cases increase almost 40% in a week as death toll passes 200
    Ebola cases have increased almost 40% in a week in the current outbreak in Congo and Uganda as the death toll passes 200.
    STAT · 2mo ago↗ source
  • cAMPfield lands $180M to build gut disease drug
    The biotech is advancing an anti-inflammatory drug that originated with vTv for inflammatory bowel diseases, leaning on a better side effect profile.
    BioPharma Dive · 2mo ago↗ source
  • STAT+: Do wearables actually help people with cardiovascular disease?
    In this edition of STAT Health Tech: A look at what researchers found about if using wearables help people with cardiovascular diseases, and more.
    STAT · 2mo ago↗ source
  • STAT+: Cambrian’s experimental longevity drug mimics exercise
    What Soon-Shiong has delivered, Encanta's RSV antiviral, and other biotech news from The Readout
    STAT · 2mo ago↗ source
  • Biogen adds more immune drugs in $1B buyout of secretive startup RayThera
    The companies didn’t specify the drugs Biogen is acquiring in the deal, though patents RayThera secured provide important clues.
    BioPharma Dive · 2mo ago↗ source
  • Pfizer CFO to step down; Denali sells a regulatory fast-pass
    A search is underway for a successor to Dave Denton, who took a job outside the pharmaceutical industry. Elsewhere, a new kind of Duchenne gene therapy got venture backing and a GSK deal paid divid…
    BioPharma Dive · 2mo ago↗ source
  • STAT+: Shingles vaccine may lower dementia risk, new study finds
    Nursing home residents who received at least one dose of shingles vaccine were 24 percent less likely to develop dementia, a new study found.
    STAT · 2mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about an FDA review of Moderna’s flu shot, J&J’s focus on cancer, and more
    Johnson & Johnson has no plans to enter the booming obesity market, opting instead to focus on diseases such as cancer
    STAT · 2mo ago↗ source
  • How many Americans can afford high-quality health care? A new poll finds the number has fallen
    A new poll shows only about half of U.S. adults could afford their health care and had access to quality care last year.
    STAT · 2mo ago↗ source
  • Six of the biggest health news stories today
    High-end infant formula scrutiny, the spread of synthetic opioids, and more health news from Morning Rounds
    STAT · 2mo ago↗ source
  • STAT+: In pancreatic cancer, Patrick Soon-Shiong makes promises he has not kept
    A wide gap exists between what Patrick Soon-Shiong says his cancer drugs can achieve and what they actually do, STAT's Adam Feuerstein writes.
    STAT · 2mo ago↗ source
  • Super-potent synthetic opioids called nitazenes are spreading across the U.S.
    Overdose deaths confirmed to involve nitazenes have risen sharply in the U.S., from 27 in 2020 to 409 in 2024, according to the CDC
    STAT · 2mo ago↗ source
  • Opinion: Congress should embrace strategic health diplomacy
    “Improving global health should be a top policy priority of the United States,” write Anand Parekh, Tom Daschle, and Bill Frist.
    STAT · 2mo ago↗ source
  • Opinion: AI’s growing appetite for power is a public health issue. Here’s a fix
    “AI is creating a new and largely overlooked strain on something fundamental to health,” write Sten H. Vermund and Patricia J. Kissinger.
    STAT · 2mo ago↗ source
  • New infant botulism outbreak puts fancy formulas under scrutiny
    A new infant botulism outbreak puts fancy formulas that position their products as safer than other options under scrutiny.
    STAT · 2mo ago↗ source
  • STAT+: Senate Democrats demand HHS provide records on federal vaccine policy
    Senate Democrats open an inquiry into the Trump administration’s remaking of U.S. vaccine policy, demanding officials produce records by next week.
    STAT · 2mo ago↗ source
  • What’s next for GLP-1 weight loss drugs?
    What’s next for GLP-1 weight loss drugs? Alex Hogan explores on the new episode of STATus Report. Watch now.
    STAT · 2mo ago↗ source
  • Kardigan extends biotech’s streak of big IPOs with $400M haul
    Including the heart drug developer’s offering, four biotechs in 2026 have raised at least $400 million in IPO proceeds — the most in a single year since 2021, according to BioPharma Dive data.
    BioPharma Dive · 2mo ago↗ source